This Vertex Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

Start Futures Trading Fast — with a $200 Bonus

Join Plus500 today and get up to $200 to start trading real futures. Practice with free paper trading, then jump into live markets with lightning-fast execution, low commissions, and full regulatory protection.

BMO Capital analyst Keith Tapper initiated coverage on ACADIA Pharmaceuticals Inc. ACAD with an Outperform rating and announced a price target of $31. ACADIA Pharmaceuticals shares fell 0.6% to close at $15.50 on Wednesday. See how other analysts view this stock.
Mizuho analyst Wei Fang initiated coverage on Grab Holdings Limited GRAB with an Outperform rating and announced a price target of $5. Grab shares fell 0.3% to close at $3.51 on Wednesday. See how other analysts view this stock.
Redburn Atlantic analyst Steve Chesney initiated coverage on Vertex Pharmaceuticals Incorporated VRTX with a Buy rating and announced a price target of $545. Vertex Pharmaceuticals shares rose 0.1% to settle at $474.00 on Wednesday. See how other analysts view this stock. See how other analysts view this stock.
Stephens & Co. analyst Mason Carrico initiated coverage on Hologic, Inc. HOLX with an Overweight rating and announced a price target of $87. Hologic shares gained 0.9% to close at $72.27 on Wednesday. See how other analysts view this stock.
Oppenheimer analyst Ian Zaffino initiated coverage on Kyndryl Holdings, Inc. KD with an Outperform rating and announced a price target of $33. Kyndryl shares fell 1% to settle at $25.28 on Wednesday. See how other analysts view this stock.